Ultrasound vendor Medison America has introduced a new accessory for its Voluson 530D 3-D ultrasound system, a breast probe that will allow clinicians to visualize lesions, tumors, and other abnormalities as 3-D shapes. The probe consists of an
Ultrasound vendor Medison America has introduced a new accessory for its Voluson 530D 3-D ultrasound system, a breast probe that will allow clinicians to visualize lesions, tumors, and other abnormalities as 3-D shapes. The probe consists of an electronic broadband 5 to 10-MHz transducer with a center frequency of 7.5 MHz.
The probe can be used not only for breast cancer imaging, but also for thyroid and testicular cancer imaging, according to Dennis Wisher, director of ultrasound education. Since the probe is held in one position while it gathers 3-D volume data, it eliminates the need for sonographers to move a transducer over the patients skin, therefore reducing scan time and increasing accuracy, the company said. 3-D images generated by the probe can be rotated, and users can manipulate images with Medisons ultrasound software, which includes niche, transparent, trapezoid, surface rendering, and live 3-D modes.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.